Skip to main content
Contact Us
Subscribe
E-Edition
61°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
29.75
+0.02 (+0.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
(VKTX) - Analyzing Viking Therapeutics's Short Interest
January 28, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2025
Via
Benzinga
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
January 24, 2025
The Danish drug giant reported a 22% weight loss over 36 weeks.
Via
Investor's Business Daily
Top 3 Health Care Stocks That Could Blast Off This Quarter
January 22, 2025
Via
Benzinga
This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?
January 22, 2025
Via
The Motley Fool
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
January 17, 2025
Via
The Motley Fool
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
January 16, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
December 30, 2024
Via
Benzinga
Looking Into Viking Therapeutics's Recent Short Interest
December 20, 2024
Via
Benzinga
We Asked Retail How Viking Therapeutics Can Restore Investor Confidence: Majority Say Pursue Buyout Talks
January 15, 2025
Oppenheimer earlier this month listed Viking as one of five biotech companies that could be prime candidates for an "aspirational" takeover.
Via
Stocktwits
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
January 14, 2025
Via
The Motley Fool
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
January 09, 2025
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Government
Exposures
Artificial Intelligence
Political
3 Mid-Cap Stocks That Could Take Off in 2025
January 09, 2025
Via
The Motley Fool
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.
Via
Benzinga
1 Under-the-Radar Stock to Buy Before It Soars by 156%, According to Select Wall Street Analysts
January 06, 2025
This is a high-risk, high-reward stock.
Via
The Motley Fool
Why Viking Therapeutics Stock Plummeted by 24% in December
January 04, 2025
Via
The Motley Fool
Should You Buy the Dip on This High-Flying Stock?
January 03, 2025
Via
The Motley Fool
StoryTrading's Secrets To January Gains - Don’t Miss These Picks
January 02, 2025
As we usher in the new year, market dynamics continue to be shaped by a blend of tax-deferral selling, the January effect, and macro uncertainties.
Via
Talk Markets
Topics
Stocks / Equities
3 Stocks That Could Be Monster Winners in 2025
December 29, 2024
Via
The Motley Fool
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
December 21, 2024
Via
The Motley Fool
My Top 10 Stocks to Buy for 2025
December 21, 2024
Via
The Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
December 20, 2024
Via
The Motley Fool
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
December 20, 2024
Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.
Via
The Motley Fool
Stock Market Tumbles, Treasury Yields Soar On Fed Rate Outlook: Weekly Review
December 20, 2024
Micron, Vertex, Novo Nordisk and Nike were notable losers on news.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
December 20, 2024
Eli Lilly and Viking Therapeutics jumped on Novo's setback.
Via
Investor's Business Daily
From Powell To Profits: Strategic Stock Picks Amid Market Uncertainty
December 19, 2024
Yesterday's market movement aligned perfectly with expectations, as the FOMC meeting drove significant volatility.
Via
Talk Markets
Topics
Stocks / Equities
What's Going On With Viking Therapeutics Stock On Wednesday?
December 18, 2024
Merck partners with Hansoh Pharma for GLP-1 drug development, while analysts highlight Viking's obesity assets as key for future growth.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 18, 2024
Via
Benzinga
Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche
December 18, 2024
Under the deal's terms, Hansoh Pharma receives $112 million up front and a potential $1.9 billion in milestone payments.
Via
Investor's Business Daily
9 Health Care Stocks With Whale Alerts In Today's Session
December 16, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.